World Health Organization Raises Alert Over Critical Lack of Obesity Jabs
Under one in 10 patients that would benefit from GLP-1 drugs like Wegovy are able to get them, warns the World Health Organization as it releases its initial advice on the medications.
Given more than one billion individuals worldwide currently obese, it is calling for broader and more equitable access to this class of drugs.
Based on estimates, more than two billion will be obese by 2030 if no action is taken.
"The latest guidelines affirms that obesity is a long-term condition that can be treated with holistic and ongoing care," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and distribution challenges are key barriers to broad availability to the injections that can assist patients in reducing significant weight, explains the organization.
GLP-1 Therapy Shortage
Even under the present most optimistic outlook, the production of such drugs could only cover approximately 100 million people – under 10% of those who need them, according to the WHO.
The guideline calls on countries and companies to widen availability, through strategies such as licensing agreements.
The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is due to expire in a number of nations in 2026.
The Way Weight-Loss Injections Work
These medications replicate a natural hormone to reduce digestion speed, suppress the appetite and increase feelings of fullness so people consume fewer calories.
Patients typically begin shedding pounds in the initial weeks of beginning the once-weekly jabs.
Evidence points to people may regain a significant portion within a year of discontinuing the medication, because their normal hunger return.
Being overweight or obese raises your chance for contracting diseases, including type 2 diabetes, heart disease, stroke, and some cancers.
Obesity affects individuals in every country and was associated with over three and a half million fatalities worldwide in 2024, according to the WHO.
